Neothetics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neothetics.com
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 162
- Registration Number
- NCT03005717
- Locations
- 🇺🇸
Juva Skin & Laser Center, New York, New York, United States
🇺🇸Clinical Testing of Beverly Hills, Beverly Hills, California, United States
🇺🇸Ablon Skin Institute And Research Center, Manhattan Beach, California, United States
Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects
- First Posted Date
- 2015-10-05
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 120
- Registration Number
- NCT02568319
- Locations
- 🇺🇸
Diagnamics, Inc., Encinitas, California, United States
🇺🇸Ablon Skin Institute and Research Center, Manhattan Beach, California, United States
🇺🇸Tennessee Clinical Research Center, Nashville, Tennessee, United States
An Open-Label Study to Evaluate Retreatment With LIPO-202
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 150
- Registration Number
- NCT02397525
- Locations
- 🇺🇸
AboutSkin Dermatology, Englewood, Colorado, United States
🇺🇸DermResearch Center of New York, Stony Brook, New York, United States
🇺🇸Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, United States
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 800
- Registration Number
- NCT02397499
- Locations
- 🇺🇸
Skin Care Research, Inc., Boca Raton, Florida, United States
🇺🇸Clinical Testing Center of Beverly Hills, Beverly Hills, California, United States
🇺🇸Clinical Science Institute, Santa Monica, California, United States
Dose Ranging Study
- Conditions
- Periumbilical Subcutaneous Adipose Tissue Reduction
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 472
- Registration Number
- NCT01802723
- Locations
- 🇺🇸
United States, California, Santa Ana, California, United States
🇺🇸United States, North Carolina, Raleigh, North Carolina, United States
🇺🇸United States, Illinois, Chicago, Illinois, United States
Dose-ranging Study
- Conditions
- Abdominal Contour Defects
- Interventions
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 200
- Registration Number
- NCT01712451
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
- Conditions
- Weight
- Interventions
- First Posted Date
- 2010-08-12
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 160
- Registration Number
- NCT01180465
An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 60
- Registration Number
- NCT01096979
Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 11
- Registration Number
- NCT00954057
Dose Ranging and Dose Frequency of LIPO-102
- Conditions
- Subcutaneous Adipose Tissue Reduction
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 54
- Registration Number
- NCT00918814